Actively Recruiting
Study of Endoscopic Ultrasound-Guided Radiofrequency Ablation to Treat Pancreatic Tumors in Patients Not Eligible for Surgery
Led by Ohio State University Comprehensive Cancer Center · Updated on 2026-03-23
84
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the safety and effectiveness of endoscopic ultrasound-guided radiofrequency ablation EUS-RFA to treat pancreatic tumors, including cysts, which can progress to pancreatic cancer. Pancreatic cancer is often fatal and hard to detect early, with a low five-year survival rate. This trial focuses on patients with high-risk pancreatic cysts who are not candidates for surgery, aiming to offer a less invasive treatment option that may reduce the need for frequent monitoring and delay or prevent cancer progression. Participants receive standard endoscopic ultrasound-guided fine-needle aspiration EUS-FNA followed by the EUS-RFA procedure. Some may have repeat EUS-RFA or EUS-guided chemoablation during follow-up surveillance. Imaging tests such as MRI, MRCP, CT scans, or additional EUS-FNA are performed at the start and during follow-up visits to monitor the cysts and treatment effects. During the study, participants are followed every 3 to 6 months for cysts 3 cm or larger, or every 6 to 12 months for smaller cysts, up to three years. Researchers evaluate the treatments effectiveness at one year and monitor long-term response and safety up to three years after EUS-RFA. Safety is assessed immediately after the procedure and at one year, with ongoing imaging and clinical assessments throughout the follow-up period.
CONDITIONS
Brief Title
Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study
Research Team
T
The Ohio State University Comprehensive Cancer Center
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here